Tag: Pharmather - Page 3 - Psychedelic Alpha

Explore psychedelic drug development via our Q1'25 🎯 Bullseye Chart.

Read more about the article PharmaTher Announces Positive Results from Study of KETABET™ for Depression

PharmaTher Announces Positive Results from Study of KETABET™ for Depression

Post published:June 7, 2022
Post category:Press Release

Read more about the article PharmaTher Signs Exclusive Worldwide License Agreement for Patented Formulation and Production Process of Ketamine and Ketamine Analogs

PharmaTher Signs Exclusive Worldwide License Agreement for Patented Formulation and Production Process of Ketamine and Ketamine Analogs

Post published:April 12, 2022
Post category:Press Release

Read more about the article PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation

PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation

Post published:February 16, 2022
Post category:Press Release

Read more about the article PharmaTher Granted FDA Orphan Drug Designation for Ketamine to Treat Status Epilepticus

PharmaTher Granted FDA Orphan Drug Designation for Ketamine to Treat Status Epilepticus

Post published:February 1, 2022
Post category:Press Release

Read more about the article PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS

PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS

Post published:January 12, 2022
Post category:Press Release

Read more about the article PharmaTher Announces Publication of Research Data for KETABET™

PharmaTher Announces Publication of Research Data for KETABET™

Post published:January 4, 2022
Post category:Press Release

Read more about the article PharmaTher Provides Update on Product Pipeline and Expected Milestones for 2022

PharmaTher Provides Update on Product Pipeline and Expected Milestones for 2022

Post published:December 21, 2021
Post category:Press Release

Read more about the article PharmaTher Announces Positive Research Results for LSD Microneedle Patch

PharmaTher Announces Positive Research Results for LSD Microneedle Patch

Post published:December 14, 2021
Post category:Press Release

Read more about the article PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent Portfolio

PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent Portfolio

Post published:November 30, 2021
Post category:Press Release

Read more about the article PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus

PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus

Post published:November 24, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.